Particle.news
Download on the App Store

Gracie McGraw Says Three Years on Ozempic Treated Her PCOS but Reawakened an Eating Disorder

Her Instagram posts frame the experience as proof that GLP‑1 drugs can ease medical symptoms while creating lasting mental‑health harm and social consequences.

Overview

  • In Instagram Stories on August 3, 2026, McGraw said she spent three years taking Ozempic to manage polycystic metabolic ovarian syndrome and that the drug helped control her symptoms but also 'brought back' an eating disorder.
  • She wrote that losing weight changed how people treated her and produced more work and social opportunities, which reopened long‑running wounds from body shaming tied to her famous family.
  • McGraw said her 'internal system is forever changed,' called the course of treatment one of the worst things she did for herself, and said the mental strain outweighed the physical benefits.
  • She later switched from Ozempic to a low dose of Mounjaro and added exercise, and she says she is doing much better now while still having occasional slip ups about her body image.
  • Her account feeds into wider questions about GLP‑1 drugs being used for weight loss, the risk of eating‑disorder relapse reported by some clinicians and survivors, and the need for compassionate public talk and clearer medical guidance.